Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7318 p410
25 September 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Rebound increase in Hib incidence starting to emerge

A rebound increase in the incidence of Hib (Haemophilus influenzae type b) disease has been reported in adults.

Routine infant immunisation with Hib was introduced in October, 1992. Adult Hib infections decreased to a low in 1998, probably as a result of “herd” immunity. But in 2002–03 Hib infections in those aged 15 years and over increased to pre-vaccine levels.

The increase in adult Hib infections is associated with lower antibody levels and may be due to the reduced opportunities for natural boosting of immunity, say workers from the Health Protection Agency Communicable Disease Surveillance Centre, who recorded the data.

They conclude that childhood immunisation programmes may have unexpected effects on the epidemiology of disease in older age groups.

The researchers also note increasing cases of Hib infection in children since 1998, ascribing lower than expected protection from vaccines, use of less immunogenic, combination vaccines in 2000–01 plus the diminishing impact of a “catch up” campaign.

Back to Top


©The Pharmaceutical Journal